(NYSE:PFE) by 0.9% during the fourth quarter, according to its most recent 13F filing with the SEC. Brown Advisory Securities LLC now owns …
Pfizer
Following U.S. election volatility some analysts have updated their recommended target prices on shares of Pfizer, Inc. (NYSE:PFE). According to the most recently released broker notes, 4 analysts have a rating of …
Pfizer
And a quick view of analyst notes show that 11 are rating the stock a buy while 1 rate PFE a strong buy. (NYSE:PFE) recently. The rating firm issued a Neutral rating to this company in a research note released on …
Pfizer
(NYSE:GE) from a hold rating to a sell rating in a research report released on Tuesday morning. The Company has 52-week high of $64.36 and 52-week low of $48.45. This forced the company to lower its organic revenue …
General Electric
Linked here is a detailed quantitative analysis of Pfizer Inc. (PFE). Below are some highlights from the above linked analysis: Company Description: Pfizer Inc. ranks as one of the world's largest pharmaceutical …
Pfizer
Pfizer was once a powerful total return producer that has morphed into a …
Pfizer
Pfizer Inc (NYSE:PFE) Average true range (ATR-14) of the company sets at 0.49, along with its weekly and monthly volatility of 1.58%, 1.41% respectively. (NYSE:PFE) by 181.8% during the fourth quarter, according to …
Pfizer
ADV now owns 38,317 shares of the biopharmaceutical company's stock valued at $1,349,000 after buying an additional 3,010 shares during the last quarter. Shares of Pfizer, Inc. Pfizer (NYSE:PFE) opened at 33.62 on …
Sells
Berenberg Bank set a $39.00 price objective on Pfizer, Inc. (NYSE:PFE) in a research report sent to investors on Friday. The firm currently has a neutral rating on the biopharmaceutical company’s stock. PFE has been the …
BNS3d
Pfizer
The stock is now trading 4.37 percent higher from its SMA-50. Pfizer Inc. (NYSE:PFE) has a Return on Assets of 0 percent, Return on Equity of 0 percent, while Return on Investment of 0 percent. The company is expected …
Ashburton